Titan Pharmaceuticals Inc (NASDAQ:TTNP)

0.95
Delayed Data
As of Apr 26
 +0.02 / +2.15%
Today’s Change
0.90
Today|||52-Week Range
3.05
-28.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues40.0K77.0K40.0K58.0K
 
 
 
 
 
Depreciation And Amortization101.0K102.0K105.0K109.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses3.4M3.6M4.0M3.3M
 
 
 
 
 
Research And Development2.1M2.5M2.7M2.3M
 
 
 
 
 
Total Operating Expenses3.5M3.7M4.1M3.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.4M-3.6M-4.1M-3.4M
 
 
 
 
 
Extraordinary Credit422.0K190.0K2.0K5.0K
 
 
 
 
 
Interest Expense On Debt0.000.000.00269.0K
 
 
Other Expenses10.0K-20.0K-123.0K-22.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.0M-3.5M-4.2M-3.7M
 
 
 
 
 
Net Income-3.0M-3.5M-4.2M-3.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS21.2M21.2M21.2M21.2M
 
 
 
 
 
Shares To Calculate EPS Diluted21.4M21.2M21.2M21.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.16-$0.17-$0.20-$0.17
 
 
 
 
 
EPS Diluted-$0.16-$0.17-$0.20-$0.17